Also listed on Mallinckrodt Critical Care Finance Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jan 12, 2027 · High confidence
20-year base term ended Sep 21, 2025
Filed Sep 21, 2005 as application 11/231,554 · Granted Apr 28, 2009
Base term plus 478 days of patent term adjustment (USPTO delay)
Today
2005
2027
Clock starts
Sep 21, 2005
Sep 21, 2005
Term ends
Jan 12, 2027
Jan 12, 2027
Granted
Apr 28, 2009
Apr 28, 2009
base term
patent term adjustment
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
478
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
16
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 478 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 21, 2005, when this application, 11/231,554, was filed | Sep 21, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +478 days, USPTO patent term adjustment record | Jan 12, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jan 12, 2027 | High confidence |
This family
| US 7,523,752 | this patent Jan 2027 | Jan 2027 |
| Application PCT/US2006/035450 | PCT application no patent term | no patent term |
| US 8,091,549 | Term ended Mar 2026 | Mar 2026 |
| US 8,397,721 | Term ended Sep 2025 | Sep 2025 |
| US 8,517,015 | Term ended Sep 2025 | Sep 2025 |
| US 8,893,717 | Term ended Sep 2025 | Sep 2025 |
| US 8,408,206 | Term ended Sep 2025 | Sep 2025 |
| US 9,351,994 | Term ended Sep 2025 | Sep 2025 |
8 of 16 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
The 40 most recent of 137 recorded documents are shown; the 97 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | CNS Therapeutics, Inc. | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Enterprises Holdings LLC (F/K/A Mallinckrodt Enterprises Holdings, Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Enterprises LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Lafayette Pharmaceuticals LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Liebel-Flarsheim Company LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Brand Pharmaceuticals LLC (F/K/A Mallinckrodt Brand Pharmaceuticals, Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Veterinary, Inc. | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt US Holdings LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Imc Exploration Company | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Meh, Inc. | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Hospital Products IP Unlimited Company (F/K/A Mallinckrodt Hospital Products IP Limited) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Ard IP Unlimited Company (F/K/A Mallinckrodt Ard IP Limited) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ocera Therapeutics LLC (F/K/A Ocera Therapeutics, Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Specgx LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Stratatech Corporation | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Sucampo Pharma Americas LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Vtesse LLC (F/K/A Vtesse Inc.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Pharmaceuticals Ireland Limited | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Mallinckrodt Pharma IP Trading Unlimited Company (F/K/A Mallinckrodt Pharma IP Trading D.A.C.) | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Infacare Pharmaceutical Corporation | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | ST Shared Services LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Therakos, Inc. | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ikaria Therapeutics LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Nov 16, 2023 reel/frame not recorded | Deutsche Bank AG New York Branch, as Collateral Agent | Ino Therapeutics LLC | Release of Patent Security Interests Recorded at Reel 035454, Frame 0768 |
| Aug 1, 2025 Reel 72331, frame 1 | Mallinckrodt Pharmaceuticals Ireland Limited | Computershare Trust Company, National Association | Security Interest |
| Aug 14, 2025 Reel 72324, frame 740 | Acquiom Agency Services LLC | Mallinckrodt Enterprises LLC; Mallinckrodt LLC; Mallinckrodt Pharma IP Trading Unlimited Company; Mallinckrodt Pharmaceuticals Ireland Limited; Ocera Therapeutics LLC; Specgx LLC; Stratatech Corporation; Sucampo Pharma Americas LLC; Vtesse LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Enterprises LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Pharma IP Trading Unlimited Company | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Mallinckrodt Pharmaceuticals Ireland Limited | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Ocera Therapeutics LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Specgx LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Stratatech Corporation | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Sucampo Pharma Americas LLC | Release of Security Interest |
| Aug 14, 2025 reel/frame not recorded | Acquiom Agency Services LLC | Vtesse LLC | Release of Security Interest |
| Oct 28, 2025 Reel 73375, frame 395 | Mallinckrodt Pharmaceuticals Ireland Limited | Goldman Sachs Bank USA, as Administrative Agent | Security Interest |
| Mar 6, 2026 Reel 75021, frame 263 | Mallinckrodt Pharmaceuticals Ireland Limited | Goldman Sachs Bank USA, as Administrative Agent | Corrective Assignment to Correct the Inclusion of US Patent 10828415 and Remove It from the Listing Previously Recorded on Reel 73375 Frame 395. Assignor(S) Hereby Confirms the Security Interest. |
| Mar 6, 2026 Reel 75021, frame 204 | Mallinckrodt Pharmaceuticals Ireland Limited | Computershare Trust Company, National Association | Corrective Assignment to Correct the Inclusion of US Patent 10828415 and Remove It from the Listing Previously Recorded on Reel 72331 Frame 1. Assignor(S) Hereby Confirms the Security Interest. |
| Apr 10, 2026 Reel 75393, frame 608 | Mallinckrodt Hospital Products IP Unlimited Company | Mallinckrodt Pharmaceuticals Ireland Limited Company | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jan 2027
Term ends Jan 12, 2027. No further fees fall due before then
Note
The 478 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
131
later US patents cite this one
That is top 5% of utility patents granted in 2009 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.